Roujeau JC - Search Results

1

HLA phenotypes and bullous cutaneous reactions to drugs.

Roujeau JC, Bracq C, Huyn NT, Chaussalet E, Raffin C, Duédari N. Roujeau JC, et al. Tissue Antigens. 1986 Oct;28(4):251-4. doi: 10.1111/j.1399-0039.1986.tb00491.x. Tissue Antigens. 1986. PMID: 3544335

2

Genetic susceptibility to toxic epidermal necrolysis.

Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Roujeau JC, et al. Arch Dermatol. 1987 Sep;123(9):1171-3. Arch Dermatol. 1987. PMID: 3477129

3

Clinical aspects of skin reactions to NSAIDs.

Roujeau JC. Roujeau JC. Scand J Rheumatol Suppl. 1987;65:131-4. doi: 10.3109/03009748709102191. Scand J Rheumatol Suppl. 1987. PMID: 2961055 Review.

4

Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis.

Wolkenstein P, Chosidow O, Fléchet ML, Robbiola O, Paul M, Dumé L, Revuz J, Roujeau JC. Wolkenstein P, et al. Among authors: roujeau jc. Contact Dermatitis. 1996 Oct;35(4):234-6. doi: 10.1111/j.1600-0536.1996.tb02364.x. Contact Dermatitis. 1996. PMID: 8957644

5

The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).

Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. Guillaume JC, et al. Among authors: roujeau jc. Arch Dermatol. 1987 Sep;123(9):1166-70. Arch Dermatol. 1987. PMID: 3632001

6

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.

Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M; RegiSCAR study group. Lonjou C, et al. Among authors: roujeau jc. Pharmacogenet Genomics. 2008 Feb;18(2):99-107. doi: 10.1097/FPC.0b013e3282f3ef9c. Pharmacogenet Genomics. 2008. PMID: 18192896

7

Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases.

Villada G, Roujeau JC, Clérici T, Bourgault I, Revuz J. Villada G, et al. Among authors: roujeau jc. Arch Dermatol. 1992 Jan;128(1):50-3. doi: 10.1001/archderm.128.1.50. Arch Dermatol. 1992. PMID: 1739287

8

[Blistering drug reactions].

Roujeau JC. Roujeau JC. Rev Prat. 2000 Jun 15;50(12):1320-3. Rev Prat. 2000. PMID: 10972073 French.

9

Identification of drug-specific public TCR driving severe cutaneous adverse reactions.

Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH, Hung SI. Pan RY, et al. Among authors: roujeau jc. Nat Commun. 2019 Aug 8;10(1):3569. doi: 10.1038/s41467-019-11396-2. Nat Commun. 2019. PMID: 31395875 Free PMC article.

10

Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants.

Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M. Wolkenstein P, et al. Among authors: roujeau jc. Arch Dermatol. 1995 May;131(5):544-51. Arch Dermatol. 1995. PMID: 7741540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

504 results

Search Page

Filters